行情

XXII

XXII

22ND CENTURY
AMEX

实时行情|Nasdaq Last Sale

0.7959
+0.0036
+0.45%
交易中 13:57 08/03 EDT
开盘
0.7912
昨收
0.7923
最高
0.8075
最低
0.7819
成交量
46.29万
成交额
--
52周最高
2.460
52周最低
0.6000
市值
1.11亿
市盈率(TTM)
-3.5643
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测XXII价格均价为11.50,最高价位11.50,最低价为11.50。

EPS

XXII 新闻

更多
22nd Century Group Reports $100M Mixed Shelf Offering
Benzinga · 07/21 19:49
22nd Century Group to Host Webcast of 2020 Second Quarter Results
GlobeNewswire · 07/09 12:00
Insider Buys 22nd Century Group's Stock
Benzinga · 07/01 15:59
'Surge in use of heated tobacco products expected after proposed ban in Hong Kong fails to get beyond legislative stage' -South China Morning Post Report
https://www.scmp.com/news/hong-kong/health-environment/article/3088105/surge-use-heated-tobacco-products-expected-after?utm_term=Autofeed&utm_medium=Social&utm_content=article&utm_source=Twitter#Echobox=15916
Benzinga · 06/08 15:40
Trade Alert: The Independent Chairman Of 22nd Century Group, Inc. (NYSEMKT:XXII), Nora Sullivan, Has Just Spent US$83k Buying 174% More Shares
Simply Wall St. · 06/08 14:03
22nd Century Group appoints new CEO and CFO
22nd Century Group (NYSEMKT:XXII) has appointed James A. Mish as CEO, effective June 22, 2020, and John Franzino as CFO, effective immediately. Most recent
seekingalpha · 06/03 16:14
22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer
GlobeNewswire · 06/03 11:45
22nd Century Group Appoints James A. Mish As Chief Executive Officer And John Franzino As Chief Financial Officer
Benzinga · 06/03 10:46

所属板块

环保服务及设备
+0.04%
专业与商业服务
+0.79%

热门股票

代码
价格
涨跌幅

XXII 简况

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.
展开

微牛提供22nd Century Group Inc(AMEX-XXII)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的XXII股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易XXII股票基本功能。